The refunds cover purchases of Golden Sunrise treatment plans sold between July 2017 and July 2020: Primary Plan of Care, Emergency D‑Virus Plan of Care, Metabolic Plan of Care, and Cancer Plan of Care (the FTC’s notices identify these specific plans).
The FTC found Golden Sunrise falsely advertised that its supplements/treatment plans could treat or cure COVID‑19 (including claims of symptom disappearance in 2–4 days), cancer, Parkinson’s disease and other serious conditions, and made unsupported claims of being “scientifically proven” or uniquely effective (the products were mainly herbs/spices and lacked reliable scientific evidence).
It depends: consumers who filed a valid claim receive a full refund of the amount they paid; eligible consumers who did not file a claim are receiving a $20 check. Overall the FTC is sending $40,700+ to 578 consumers.
Check eligibility by whether you bought the listed Golden Sunrise treatment plans between July 2017 and July 2020 and whether you received a mailed Claim ID or payment notice; the administrator mailed Claim IDs to eligible consumers. To file a claim you’ll need the Claim ID mailed to you (and usual proof of purchase if requested by the administrator) — contact the refund administrator Simpluris for specifics at 1‑844‑804‑3922 or info@goldensunriserefund.com.
Submit a claim online at the claims portal maintained for this settlement: www.goldensunriserefund.com. Use the Claim ID mailed to you; the FTC’s pages direct eligible consumers to that site and provide the refund administrator contact (Simpluris) for help. Deadline to file is May 12, 2026.
Yes. Payments come from FTC enforcement of its case: Dr. Stephen Meis stipulated to an order (June 2021) requiring him to pay $103,420 to fund refunds; in September 2025 the U.S. District Court (E.D. Cal.) entered summary decision in the FTC’s favor against Golden Sunrise, and the FTC is using collected funds to pay consumers. Case details and court documents are on the FTC case page and related press releases.
Golden Sunrise Nutraceutical and related companies were defendant in the FTC litigation; litigation continued against Golden Sunrise, Golden Sunrise Pharmaceutical, and Huu Tieu (the court entered summary decision in 2025). The refunds are funded by money collected from defendants (including the $103,420 paid by Dr. Stephen Meis); contact information for the refund administrator is on the FTC page. The FTC press releases do not state whether Golden Sunrise remains in business today.